UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for previously untreated patients with multiple myeloma.

Cavenagh, JD; Popat, R; Curry, N; Stec, J; Morris, TC; Drake, M; Agrawal, S; ... Oakervee, H; + view all (2004) PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for previously untreated patients with multiple myeloma. In: (Proceedings) 46th Annual Meeting of the American-Society-of-Hematology. (pp. 413A-413A). AMER SOC HEMATOLOGY

Full text not available from this repository.
Type: Proceedings paper
Title: PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for previously untreated patients with multiple myeloma.
Event: 46th Annual Meeting of the American-Society-of-Hematology
Location: San Diego, CA
Dates: 04 December 2004 - 07 December 2004
Keywords: Science & Technology, Life Sciences & Biomedicine, Hematology
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
URI: http://discovery.ucl.ac.uk/id/eprint/1458185
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item